T. Rowe Price Investment Management, Inc.
Position in BMY — Bristol Myers Squibb Co
CIK 1897612
BALTIMORE, MD
Position in BMY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,163,085
+$1,018,985 QoQ
Shares Held
19,177
+516.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $1,197,745,873 across 8 Drug Manufacturers - General names. BMY ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,026,556 | $944,195,412 | |
| 2 | BIIB |
Biogen Inc.
|
1,160,989 | $212,844,113 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
230,625 | $32,142,206 | |
| 4 | JNJ |
Johnson & Johnson
|
16,925 | $4,137,147 | |
| 5 | ABBV |
AbbVie Inc.
|
5,805 | $1,262,529 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
19,177 | $1,163,085 | |
| 7 | PFE |
Pfizer Inc
|
35,847 | $1,006,583 | |
| 8 | MRK |
Merck & Co., Inc.
|
8,270 | $994,798 |
All Filings in BMY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,163,085 | 19,177 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $144,100 | 3,113 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||